907217-45-2

Upstream product

• 131744-19-9 (4S)-4-benzyl-1,3-oxazolidine-2-thione 
• 111-64-8 n-octanoic acid chloride 

Downstream Products

• 907217-48-5 (2S,3R)-2-Hexyl-3-hydroxy-5-oxo-decanoic acid benzyl ester 
• 907217-49-6 (2S,3R,5S)-2-Hexyl-3,5-dihydroxy-decanoic acid benzyl ester 
• 907217-47-4 (S)-2-[(R)-1-Hydroxy-2-(2-pentyl-[1,3]dithian-2-yl)-ethyl]-octanoic acid benzyl ester 
• 907217-50-9 (2S,3R,5S)-2-Hexyl-3-hydroxy-5-triisopropylsilanyloxy-decanoic acid benzyl ester 
• 907217-51-0 (2S,3R,5S)-2-Hexyl-3-methanesulfonyloxy-5-triisopropylsilanyloxy-decanoic acid benzyl ester 
• 113276-96-3 valilactone 
• 907217-46-3 (S)-1-((S)-4-Benzyl-2-thioxo-oxazolidin-3-yl)-2-[(R)-1-hydroxy-2-(2-pentyl-[1,3]dithian-2-yl)-ethyl]-octan-1-one 

Relevant academic research and scientific papers

An expeditious enantioselective total synthesis of valilactone

The title compound was synthesized through an expeditious route using Crimmins aldolization to establish the two key stereogenic centers and a hydroxyl group activation (HGA) protocol to construct the anti α,β-disubstituted β-lactone from the corresponding syn aldol.